Skip to main content

Vaccine Administration & Aftercare

COVID-19 vaccines are being administered throughout British Columbia under the BC COVID-19 Immunization Plan

Supporting individuals in making an informed decision and giving voluntary consent is critical to the immunization process.

The Canadian National Vaccine Safety (CANVAS) Network is a national platform that monitors vaccine safety after vaccines are approved for use. Individuals may choose to enrol in safety monitoring by going to the CANVAS-COVID.ca webpage. 

The following resources include information for new or existing vaccine providers to safely administer COVID-19 vaccines. 

‎National Resources

Health Canada and the Public Health Agency of Canada, in collaboration with the Association of Medical Microbiology and Infectious Disease Canada and the National Collaborating Centre for Infectious Diseases have created and provided access to a series of webinars on immunization clinic planning, vaccine planning and administration.

WHAT: Webinars for COVID-19 vaccines - Health Canada, Public Health Agency of Canada, Association of Medical Microbiology and Infectious Disease Canada, National Collaborating Centre for Infectious Diseases

AUDIENCE: Health Care Providers

USE: Webinars emphasizing topics such as COVID-19 vaccine foundations, NACI recommendations on the use of the Pfizer-BioNTech and Moderna COVID-19 vaccines, emerging issues (eg. delayed injection site reactions, allergies and LDV syringes), planning for immunization clinics.


Vaccine Manufacturer Resources

Pfizer BioNTech has provided supplemental information on their COVID-19 mRNA vaccine for Canadian Health Care Providers.

WHAT: Short video - Pfizer-BioNTech

AUDIENCE: Immunizers of the Pfizer-BioNTech COVID-19 mRNA vaccine.

USE: Additional information about the preparation and administration of Pfizer-BioNTech COVID-19 Vaccine.

 
Infection prevention and control and workplace health and safety is an important component in the provision of COVID-19 vaccines.

  • Immunizers should wear a medical mask and eye protection as should other staff who are not able to maintain a two-metre physical distance (e.g., recovery room monitors and first aid providers);
  • Clean your hands before and after providing immunization. Wearing a watch can impede good hand hygiene practices.
  • Immunizers need not wear gloves. If gloves are used, they should be changed between clients and hand hygiene performed after gloves are removed. 
  • PPE including medical mask, eye protection, gown and gloves should be immediately available to all personnel who need to provide first aid or respond to a health emergency.

This document highlights considerations for PPE selection while delivering COVID-19 vaccines.


AUDIENCE: COVID-19 Immunizers

USE: Though this document was initially intended to guide the delivery of seasonal influenza in the COVID-19 environment, much can be used for the provision of COVID-19 vaccines in the COVID-19 environment – note page 4 considerations for PPE selection.

 This guidance outlines the infection prevention and control measures required for COVID-19 immunization clinics in community settings.

AUDIENCE: Clinic operators

USE:  This document outlines measures required for the set up and safe operation of COVID-19 immunization clinics in community settings (e.g. community pharmacies, schools, community centres, arenas).

 
 

Pfizer BioNTech and Moderna have provided supplemental information on their COVID-19 mRNA vaccines for Canadian Health Care Providers.

WHAT: The S.T.E.P.S to COVID-19 Vaccination Leaflet– Pfizer-BioNTech

AUDIENCE: Individuals supporting the storage, handling and administration of the Pfizer-BioNTech COVID-19 mRNA vaccine.

USE: Reference guide reviewing the S.T.E.P.S (Store, Tally doses and thaw, Equilibrate and dilute, Prepare and administer, Safely dispose and ship back materials) for the Pfizer-BioNTech COVID-19 mRNA vaccine.


WHAT: Storage and Handling (page 2) – Moderna

AUDIENCE: Individuals supporting the dosing and administration of the Moderna COVID-19 mRNA vaccine.

USE: Page 2 of this reference guide illustrates the dosing, scheduling and administration of the Moderna COVID-19 mRNA vaccine.

‎The following are the product specific product monographs, including patient information, for each of the COVID-19 vaccines authorized for use in Canada. 

Moderna: Moderna Product Monograph

Pfizer-BioNTech: Pfizer-BioNTech Product Monograph

AstraZeneca: AstraZeneca Product Monograph

COVISHIELD: COVISHIELD Product Monograph

Janssen: Janssen Product Monograph

 
 
SOURCE: Vaccine Administration & Aftercare ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Centre for Disease Control. All Rights Reserved.

    Copyright © 2021 Provincial Health Services Authority.